Re: Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

被引：0
|
作者：
Chang, Sam S.
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 204卷 / 03期
关键词：
D O I：
10.1097/JU.0000000000001175.01
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：617 / 617
页数：1
相关论文
共 50 条
  • [1] Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer
    Fu, Hangcheng
    Zhu, Yu
    Wang, Yiwei
    Liu, Zheng
    Zhang, Junyu
    Xie, Huyang
    Fu, Qiang
    Dai, Bo
    Ye, Dingwei
    Xu, Jiejie
    CLINICAL CANCER RESEARCH, 2018, 24 (13) : 3069 - 3078
  • [2] Identification and validation of stromal immunotype predict survival and benefit from neoadjuvant chemotherapy in patients of breast cancer
    Ji, Fei
    Yang, Ciqiu
    Zhang, Liulu
    Yang, Mei
    Li, Jieqing
    Gao, Hongfei
    Zhu, Teng
    Cheng, Minyi
    Wang, Kun
    CANCER RESEARCH, 2021, 81 (04)
  • [3] Identification and validation of stromal immunotype predict survival and benefit from neoadjuvant chemotherapy in patients of breast cancer.
    Ji, Fei
    Yang, Ci-Qiu
    Zhang, Liulu
    Yang, Mei
    Li, Jieqing
    Gao, Hong-Fei
    Zhu, Teng
    Cheng, Min-Yi
    Wang, Kun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] Re: A Systematic Review of Neoadjuvant and Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Sagalowsky, Arthur I.
    EUROPEAN UROLOGY, 2013, 63 (03) : 579 - 580
  • [5] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [6] Neoadjuvant Chemotherapy in Patients with Muscle-invasive Bladder Cancer: Which Patients Benefit?
    Niegisch, Guenter
    Lorch, Anja
    Droller, Michael J.
    Lavery, Hugh J.
    Stensland, Kristian D.
    Albers, Peter
    EUROPEAN UROLOGY, 2013, 64 (03) : 355 - 357
  • [7] Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer
    Zhou, Lin
    Xu, Le
    Chen, Lingli
    Fu, Qiang
    Liu, Zheng
    Chang, Yuan
    Lin, Zongming
    Xu, Jiejie
    ONCOIMMUNOLOGY, 2017, 6 (04):
  • [8] Perioperative chemotherapy: the case for adjuvant chemotherapy for muscle-invasive bladder cancer
    So, Alan
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2008, 2 (03): : 225 - 227
  • [9] Clarifying the indications for adjuvant chemotherapy in muscle-invasive bladder cancer
    Peter Albers
    Nature Clinical Practice Urology, 2007, 4 : 184 - 185
  • [10] Clarifying the indications for adjuvant chemotherapy in muscle-invasive bladder cancer
    Albers, Peter
    NATURE CLINICAL PRACTICE UROLOGY, 2007, 4 (04): : 184 - 185
12345